JP2010222379A5 - - Google Patents

Download PDF

Info

Publication number
JP2010222379A5
JP2010222379A5 JP2010150627A JP2010150627A JP2010222379A5 JP 2010222379 A5 JP2010222379 A5 JP 2010222379A5 JP 2010150627 A JP2010150627 A JP 2010150627A JP 2010150627 A JP2010150627 A JP 2010150627A JP 2010222379 A5 JP2010222379 A5 JP 2010222379A5
Authority
JP
Japan
Prior art keywords
seq
residues
fetoprotein
acid sequence
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010150627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010222379A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010222379A publication Critical patent/JP2010222379A/ja
Publication of JP2010222379A5 publication Critical patent/JP2010222379A5/ja
Pending legal-status Critical Current

Links

JP2010150627A 1997-02-13 2010-06-30 肝細胞癌の予防又は処置のための組成物 Pending JP2010222379A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3837597P 1997-02-13 1997-02-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006038626A Division JP2006188528A (ja) 1997-02-13 2006-02-15 肝細胞癌の予防又は処置のための組成物

Publications (2)

Publication Number Publication Date
JP2010222379A JP2010222379A (ja) 2010-10-07
JP2010222379A5 true JP2010222379A5 (enExample) 2010-11-18

Family

ID=21899585

Family Applications (3)

Application Number Title Priority Date Filing Date
JP53591698A Expired - Lifetime JP3816959B2 (ja) 1997-02-13 1998-02-13 肝細胞癌の予防および処置
JP2006038626A Withdrawn JP2006188528A (ja) 1997-02-13 2006-02-15 肝細胞癌の予防又は処置のための組成物
JP2010150627A Pending JP2010222379A (ja) 1997-02-13 2010-06-30 肝細胞癌の予防又は処置のための組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP53591698A Expired - Lifetime JP3816959B2 (ja) 1997-02-13 1998-02-13 肝細胞癌の予防および処置
JP2006038626A Withdrawn JP2006188528A (ja) 1997-02-13 2006-02-15 肝細胞癌の予防又は処置のための組成物

Country Status (8)

Country Link
US (1) US20020031520A1 (enExample)
EP (1) EP0979239B1 (enExample)
JP (3) JP3816959B2 (enExample)
KR (1) KR100460583B1 (enExample)
CN (2) CN1222536C (enExample)
AU (1) AU6435398A (enExample)
DE (1) DE69836209D1 (enExample)
WO (1) WO1998035981A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058922A2 (en) * 2000-02-10 2001-08-16 The Regents Of The University Of California Method and compositions for treating hepatocellular cancer
FI118263B (fi) * 2002-10-09 2007-09-14 Timo Kalevi Korpela Kaspaasiaktiivisuutta säätelevät peptidit
US8932829B2 (en) 2005-07-07 2015-01-13 Elena Dudich Recombinant alpha-fetoprotein and compositions thereof
GB0617564D0 (en) * 2006-09-06 2006-10-18 Ucl Business Plc Peptides and methods
KR100900742B1 (ko) * 2007-05-17 2009-06-08 크레아젠 주식회사 인간 간암 동물모델 및 이를 이용한 수지상세포-유래 간암면역치료제의 예방 및 치료 효능을 분석하는 방법
AU2010309438A1 (en) * 2009-10-22 2012-06-07 Ricardo J. Moro Peptides that bind the alpha-fetoprotein (AFP) receptor and uses thereof
US10048271B2 (en) 2012-12-11 2018-08-14 Albert Einstein College Of Medicine, Inc. Methods for high throughput receptor:ligand identification
WO2016161390A1 (en) 2015-04-03 2016-10-06 Eureka Therapeutics, Inc. Constructs targeting afp peptide/mhc complexes and uses thereof
CN105126074A (zh) * 2015-09-30 2015-12-09 中国药科大学 多肽afp12在制备抗肿瘤药物中的应用
CN105524884A (zh) * 2016-02-29 2016-04-27 时宏珍 Hla-a0201限制性抗afp抗原特异性ctl的制备方法
AU2017266905B2 (en) 2016-05-18 2022-12-15 Albert Einstein College Of Medicine, Inc. Variant PD-L1 polypeptides, T-cell modulatory multimeric polypeptides, and methods of use thereof
US11505591B2 (en) 2016-05-18 2022-11-22 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
KR102760578B1 (ko) 2016-12-22 2025-02-03 큐 바이오파마, 인크. T-세포 조절 다량체 폴리펩타이드 및 이의 사용 방법
US11851471B2 (en) 2017-01-09 2023-12-26 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
IL269000B2 (en) 2017-03-15 2024-06-01 Cue Biopharma Inc Methods for modulating an immune response
CN111886241A (zh) 2018-01-09 2020-11-03 库尔生物制药有限公司 多聚体t细胞调节多肽及其使用方法
WO2021231376A2 (en) 2020-05-12 2021-11-18 Cue Biopharma, Inc. Multimeric t-cell modulatory polypeptides and methods of use thereof
EP4211149A4 (en) 2020-09-09 2024-10-09 Cue Biopharma, Inc. MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
CN113416729B (zh) * 2021-05-18 2022-11-22 遵义医科大学附属医院 一种肝脏靶向调控甲胎蛋白基因的shRNA和cDNA及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH025866A (ja) * 1988-06-27 1990-01-10 Kansai Shin Gijutsu Kenkyusho:Kk ヒトアルファフェトプロテインドメインｉ遺伝子、対応プラスミド組換体、対応形質転換体、該ドメインｉの製造法及び製造された該ドメインｉ
IT1226551B (it) * 1988-07-29 1991-01-24 Sclavo Spa Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita' verso l'alfa- fetoproteina e loro impiego in campo diagnostico
US5633234A (en) * 1993-01-22 1997-05-27 The Johns Hopkins University Lysosomal targeting of immunogens
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
WO1996022787A1 (en) * 1995-01-24 1996-08-01 Murgita Robert A Recombinant human alpha-fetoprotein and uses thereof

Similar Documents

Publication Publication Date Title
ES2545895T3 (es) Proteína de fusión anticancerígena
JP2015525217A5 (enExample)
JP2014525439A5 (enExample)
NZ593833A (en) Extended recombinant polypeptides and compositions comprising same
EP3919507A3 (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
JP2024041747A5 (enExample)
JP2009268467A5 (enExample)
EP3712165A3 (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
HRP20240135T1 (hr) Fgf21 mutanti i njihove upotrebe
JP2011530309A5 (enExample)
JP2014224126A5 (enExample)
MX2021000030A (es) Metodos y composiciones que utilizan polipeptidos variantes klotho.
JP2015528443A5 (enExample)
ES2545457T3 (es) Vacunas de péptidos para cánceres que expresan los polipéptidos DEPDC1
CO6190536A2 (es) Vacunas peptidicas para canceres que expresan antigenos asociados con tumores
JP2015514395A5 (enExample)
PH12013500050A1 (en) Anticancer fusion protein
JP2012515794A5 (enExample)
NZ705899A (en) Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (trem-1) trem-like transcript 1 (tlt-1) and uses thereof
CO6430475A2 (es) Polipéptidos que tienen actividad de celulasa
EP2589658A4 (en) PARTIAL REGION POLYPEPTIDE OF REIC / DKK-3 PROTEIN
NZ609916A (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
FI3737399T3 (fi) ATF5-peptidivariantit ja niiden käytöt
JP2010265269A5 (enExample)
JP2013523084A5 (enExample)